BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT05271318-completion@plaintrial.com
DTSTAMP:20261025T035237Z
DTSTART;VALUE=DATE:202708
SUMMARY:Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembro
 lizumab or Pembrolizumab (Phase 1a) and Pegylated Liposomal Doxorubicin (P
 hase 1b) as Treatment for Ovarian Cancer. — estimated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT05271318
URL:https://plaintrial.com/trial/NCT05271318
END:VEVENT
END:VCALENDAR